Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1544

Similar articles for PubMed (Select 17308128)

1.

G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.

Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M.

Cancer Res. 2007 Feb 15;67(4):1859-66.

2.

The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.

Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Andò S.

J Biol Chem. 2004 Jun 25;279(26):27008-16. Epub 2004 Apr 16.

3.

Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.

Madeo A, Maggiolini M.

Cancer Res. 2010 Jul 15;70(14):6036-46. doi: 10.1158/0008-5472.CAN-10-0408. Epub 2010 Jun 15.

4.

17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.

Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Andò S, Maggiolini M.

Mol Pharmacol. 2006 Oct;70(4):1414-23. Epub 2006 Jul 11.

5.

The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.

Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC.

Cancer Res. 2010 Feb 1;70(3):1184-94. doi: 10.1158/0008-5472.CAN-09-3068. Epub 2010 Jan 19.

7.

The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.

Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.

Mol Endocrinol. 2006 Mar;20(3):631-46. Epub 2005 Oct 20.

PMID:
16239258
8.

The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line.

Sirianni R, Chimento A, Ruggiero C, De Luca A, Lappano R, Andò S, Maggiolini M, Pezzi V.

Endocrinology. 2008 Oct;149(10):5043-51. doi: 10.1210/en.2007-1593. Epub 2008 Jun 19.

PMID:
18566133
9.
10.

Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells.

Tian L, Wu Z, Zhao Y, Meng Y, Si Y, Fu X, Mu Y, Han W.

J Endocrinol. 2009 Jul;202(1):167-77. doi: 10.1677/JOE-09-0054. Epub 2009 Apr 29.

11.
12.

GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.

Vivacqua A, Romeo E, De Marco P, De Francesco EM, Abonante S, Maggiolini M.

Breast Cancer Res Treat. 2012 Jun;133(3):1025-35. doi: 10.1007/s10549-011-1901-8. Epub 2011 Dec 7.

PMID:
22147081
13.
15.

Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.

O'Donnell AJ, Macleod KG, Burns DJ, Smyth JF, Langdon SP.

Endocr Relat Cancer. 2005 Dec;12(4):851-66.

16.

17 beta-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ER alpha.

Chimento A, Sirianni R, Delalande C, Silandre D, Bois C, Andò S, Maggiolini M, Carreau S, Pezzi V.

Mol Cell Endocrinol. 2010 May 14;320(1-2):136-44. doi: 10.1016/j.mce.2010.01.035. Epub 2010 Feb 2.

PMID:
20132863
18.

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.

Girgert R, Emons G, Gründker C.

Breast Cancer Res Treat. 2012 Jul;134(1):199-205. doi: 10.1007/s10549-012-1968-x.

19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk